These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35032429)

  • 1. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
    Georg P; Astaburuaga-García R; Bonaguro L; Brumhard S; Michalick L; Lippert LJ; Kostevc T; Gäbel C; Schneider M; Streitz M; Demichev V; Gemünd I; Barone M; Tober-Lau P; Helbig ET; Hillus D; Petrov L; Stein J; Dey HP; Paclik D; Iwert C; Mülleder M; Aulakh SK; Djudjaj S; Bülow RD; Mei HE; Schulz AR; Thiel A; Hippenstiel S; Saliba AE; Eils R; Lehmann I; Mall MA; Stricker S; Röhmel J; Corman VM; Beule D; Wyler E; Landthaler M; Obermayer B; von Stillfried S; Boor P; Demir M; Wesselmann H; Suttorp N; Uhrig A; Müller-Redetzky H; Nattermann J; Kuebler WM; Meisel C; Ralser M; Schultze JL; Aschenbrenner AC; Thibeault C; Kurth F; Sander LE; Blüthgen N; Sawitzki B;
    Cell; 2022 Feb; 185(3):493-512.e25. PubMed ID: 35032429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
    Chilunda V; Martinez-Aguado P; Xia LC; Cheney L; Murphy A; Veksler V; Ruiz V; Calderon TM; Berman JW
    Front Immunol; 2021; 12():665773. PubMed ID: 34108966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.
    Hoste L; Roels L; Naesens L; Bosteels V; Vanhee S; Dupont S; Bosteels C; Browaeys R; Vandamme N; Verstaen K; Roels J; Van Damme KFA; Maes B; De Leeuw E; Declercq J; Aegerter H; Seys L; Smole U; De Prijck S; Vanheerswynghels M; Claes K; Debacker V; Van Isterdael G; Backers L; Claes KBM; Bastard P; Jouanguy E; Zhang SY; Mets G; Dehoorne J; Vandekerckhove K; Schelstraete P; Willems J; ; Stordeur P; Janssens S; Beyaert R; Saeys Y; Casanova JL; Lambrecht BN; Haerynck F; Tavernier SJ
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34914824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.
    Zenarruzabeitia O; Astarloa-Pando G; Terrén I; Orrantia A; Pérez-Garay R; Seijas-Betolaza I; Nieto-Arana J; Imaz-Ayo N; Pérez-Fernández S; Arana-Arri E; Borrego F
    Front Immunol; 2021; 12():655934. PubMed ID: 33777054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
    Ma Y; Qiu F; Deng C; Li J; Huang Y; Wu Z; Zhou Y; Zhang Y; Xiong Y; Yao Y; Zhong Y; Qu J; Su J
    Genome Med; 2022 Feb; 14(1):16. PubMed ID: 35172892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019.
    Magro CM; Mulvey JJ; Laurence J; Seshan S; Crowson AN; Dannenberg AJ; Salvatore S; Harp J; Nuovo GJ
    Hum Pathol; 2020 Dec; 106():106-116. PubMed ID: 33058948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell multi-omics analysis of the immune response in COVID-19.
    Stephenson E; Reynolds G; Botting RA; Calero-Nieto FJ; Morgan MD; Tuong ZK; Bach K; Sungnak W; Worlock KB; Yoshida M; Kumasaka N; Kania K; Engelbert J; Olabi B; Spegarova JS; Wilson NK; Mende N; Jardine L; Gardner LCS; Goh I; Horsfall D; McGrath J; Webb S; Mather MW; Lindeboom RGH; Dann E; Huang N; Polanski K; Prigmore E; Gothe F; Scott J; Payne RP; Baker KF; Hanrath AT; Schim van der Loeff ICD; Barr AS; Sanchez-Gonzalez A; Bergamaschi L; Mescia F; Barnes JL; Kilich E; de Wilton A; Saigal A; Saleh A; Janes SM; Smith CM; Gopee N; Wilson C; Coupland P; Coxhead JM; Kiselev VY; van Dongen S; Bacardit J; King HW; ; Rostron AJ; Simpson AJ; Hambleton S; Laurenti E; Lyons PA; Meyer KB; Nikolić MZ; Duncan CJA; Smith KGC; Teichmann SA; Clatworthy MR; Marioni JC; Göttgens B; Haniffa M
    Nat Med; 2021 May; 27(5):904-916. PubMed ID: 33879890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell dysregulation in COVID-19.
    Kalfaoglu B; Almeida-Santos J; Tye CA; Satou Y; Ono M
    Biochem Biophys Res Commun; 2021 Jan; 538():204-210. PubMed ID: 33220925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4
    Meckiff BJ; Ramírez-Suástegui C; Fajardo V; Chee SJ; Kusnadi A; Simon H; Eschweiler S; Grifoni A; Pelosi E; Weiskopf D; Sette A; Ay F; Seumois G; Ottensmeier CH; Vijayanand P
    Cell; 2020 Nov; 183(5):1340-1353.e16. PubMed ID: 33096020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).
    Lanier LL; Kipps TJ; Phillips JH
    J Exp Med; 1985 Dec; 162(6):2089-106. PubMed ID: 2415663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
    Payen D; Cravat M; Maadadi H; Didelot C; Prosic L; Dupuis C; Losser MR; De Carvalho Bittencourt M
    Front Immunol; 2020; 11():580250. PubMed ID: 33178207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the immune response in coronavirus disease 2019.
    Mohamed Khosroshahi L; Rezaei N
    Cell Biol Int; 2021 Apr; 45(4):702-707. PubMed ID: 33289192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19.
    Kim DM; Kim Y; Seo JW; Lee J; Park U; Ha NY; Koh J; Park H; Lee JW; Ro HJ; Yun NR; Kim DY; Yoon SH; Na YS; Moon DS; Lim SC; Kim CM; Jeon K; Kang JG; Jang NY; Jeong H; Kim J; Cheon S; Sohn KM; Moon JY; Kym S; Han SR; Lee MS; Kim HJ; Park WY; Choi JY; Shin HW; Kim HY; Cho CH; Jeon YK; Kim YS; Cho NH
    Cell Rep; 2021 Oct; 37(1):109798. PubMed ID: 34587481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.
    Kalfaoglu B; Almeida-Santos J; Tye CA; Satou Y; Ono M
    Front Immunol; 2020; 11():589380. PubMed ID: 33178221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
    You M; Chen L; Zhang D; Zhao P; Chen Z; Qin EQ; Gao Y; Davis MM; Yang P
    Nat Cell Biol; 2021 Jun; 23(6):620-630. PubMed ID: 34108657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 activated T cells (T-LAK) express CD16 antigen and are triggered to target cell lysis by bispecific antibody.
    Nitta T; Nakata M; Yagita H; Okumura K
    Immunol Lett; 1991 Apr; 28(1):31-7. PubMed ID: 1830029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Immune Profiling Reveals CD56
    Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
    J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
    Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
    Front Immunol; 2021; 12():767981. PubMed ID: 34804055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
    Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
    Front Immunol; 2021; 12():716361. PubMed ID: 34491250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.